{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T22:17:58Z","timestamp":1771539478383,"version":"3.50.1"},"reference-count":15,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T00:00:00Z","timestamp":1355184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2013,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>We recently showed in a single centre trial that low\u2010dose secondary prophylaxis in severe\/moderate haemophilia patients with arthropathy is feasible and beneficial. However, this regimen has not been validated in a multicentre setting and what obstacles are there to prophylaxis remain unclear. (i) Benefit study: to confirm the benefits of similar prophylaxis protocol in severe\/moderate haemophilia <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">HA<\/jats:styled-content>) in a multicentre setting in China. (ii) Follow\u2010up obstacle study: to investigate obstacles in compliance to prophylaxis treatment. (i) Benefit study: severe\/moderate <jats:styled-content style=\"fixed-case\">HA<\/jats:styled-content> children with arthropathy from 15 centres were enrolled to undergo an 8\u2010week on\u2010demand treatment, followed by 6 to 12\u2010week low\u2010dose secondary prophylaxis. Outcomes compared in the two periods include joint and severe bleeding, daily activities and factor consumption. (ii) Obstacle study: questionnaires to investigators to collect data on patient and centre factors contributing to inability to comply with prophylaxis. We enrolled 191 patients from 15 centres. Sixty\u2010six (34.6%) from three centres completed the prophylaxis protocol, and they had significantly decreased bleeding (78.8% haemarthrosis and 68.9% severe bleedings) and improved daily activities with no increase in factor consumption over that in the on\u2010demand therapy period. The remaining 125 patients from 12 centres were not compliant to the prophylaxis protocol; questionnaire data indicated that the major obstacles were inability of patients\/parents to accept (41.7%) or to adhere (33.3%) to the prophylaxis protocol, mostly because of failure to understand the benefits and to accept the frequent injections. Non\u2010availability of a centre comprehensive care team was another important determinant. Short\u2010term low\u2010dose secondary prophylactic therapy is beneficial without increasing factors consumption for severe\/moderate <jats:styled-content style=\"fixed-case\">HA<\/jats:styled-content> with arthropathy in a multi\u2010centre setting in <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>hina. Obstacles to overcome must include improvement in comprehensive care and in education to patient\/parents and healthcare personnel.<\/jats:p>","DOI":"10.1111\/j.1365-2516.2012.02926.x","type":"journal-article","created":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T23:37:56Z","timestamp":1355269076000},"page":"27-34","source":"Crossref","is-referenced-by-count":61,"title":["Short\u2010term low\u2010dose secondary prophylaxis for severe\/moderate haemophilia A children is beneficial to reduce bleed and improve daily activity, but there are obstacle in its execution: a multi\u2010centre pilot study in China"],"prefix":"10.1111","volume":"19","author":[{"given":"L.","family":"Tang","sequence":"first","affiliation":[{"name":"Hemophilia Work Group Beijing Children's Hospital affiliated to Capital Medical University Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Wu","sequence":"additional","affiliation":[{"name":"Hemophilia Work Group Beijing Children's Hospital affiliated to Capital Medical University Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sun","sequence":"additional","affiliation":[{"name":"Hemophilia Center Nanfang Hospital affiliated to Nanfang Medical University Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hemophilia Center of Shandong Province Jinan China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Feng","sequence":"additional","affiliation":[{"name":"Hemophilia Center Nanfang Hospital affiliated to Nanfang Medical University Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hemophilia Center of Shandong Province Jinan China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.\u2010H.","family":"Luke","sequence":"additional","affiliation":[{"name":"University of Ottawa Children's Hospital of Eastern Ontario Ottawa ON Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.\u2010C.","family":"Poon","sequence":"additional","affiliation":[{"name":"Foothills Hospital University of Calgary Calgary AB Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,12,11]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2003.00870.x"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2000.00427.x"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.00998.x"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2008.01821.x"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2010.02348.x"},{"key":"e_1_2_8_7_1","unstructured":"World Federation of Hemophilia.Guidelines for the Management of Hemophilia 2005. Available athttp:\/\/www.wfh.org. Accessed September 22 2010."},{"key":"e_1_2_8_8_1","unstructured":"Lifecord Stat\u2010Korea (CRO) HwangJH.Pharmacokinetic efficacy and safety study of GreenEight a double (solvent\/detergent\u00a0+\u00a0heating) virus inactivated plasma derived factor VIII concentrate in previously treated type\u2010A hemophilia patients. Green Cross Corporation Clinical Study Report China 2005."},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2005.01142.x"},{"key":"e_1_2_8_10_1","first-page":"116","article-title":"Clinical material and current situation analysis in children with haemophilia","volume":"14","author":"Wu RH","year":"2008","journal-title":"Chinese J Thromb Hemost"},{"key":"e_1_2_8_11_1","first-page":"326","article-title":"X\u2010ray changes and clinical analysis in 101 cases of haemophilic arthropathy","volume":"22","author":"Sun SJ","year":"2006","journal-title":"Clin Med China"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0268-960X(03)00038-9"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830470209"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.420960.x"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1351-8216.2001.00120.x"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1992.tb00546.x"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2516.2012.02926.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2516.2012.02926.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T22:14:13Z","timestamp":1697321653000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2516.2012.02926.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,11]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["10.1111\/j.1365-2516.2012.02926.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2516.2012.02926.x","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,11]]}}}